Drugs Slip Past FDA, Sell Unapproved by the Millions
Ballay Pharmaceuticals Inc. had a choice nine years ago: seek U.S. approval to sell a prescription decongestant or slip the drug on the market and hope regulators wouldn't order…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Ballay Pharmaceuticals Inc. had a choice nine years ago: seek U.S. approval to sell a prescription decongestant or slip the drug on the market and hope regulators wouldn't order…
You must be logged in to post a comment.